Over the last decade, the incidence of tuberculosis (TB) in the pediatric population has increased worldwide. In 1993, 1721 children in the United States developed tuberculosis, a 40% increase from 1987.¹ The World Health Organization estimates that 4.5 million tuberculosis-related deaths will occur among children in the 1990s.^2,3 With the increasing incidence of tuberculosis, an accompanying rise in the incidence of tuberculids and other skin manifestations of this disease may occur.

Erythema induratum of Bazin (EIB) is a tuberculid characterized by chronic or recurrent tender subcutaneous nodules which sometime ulcerate. The lesions typically are located on the lower extremities of adult women.⁴ Histologically, a lobular granulomatous panniculitis with extensive vasculitis is seen.⁵ Clinicopathologic correlation is required for the diagnosis, because no single finding is pathognomonic. After 50 years of controversy over its relationship to tuberculosis, EIB now is generally accepted to be a true tuberculid and histologically classified as a subset of nodular vasculitis.⁵ To the best of our knowledge, the youngest patient with EIB reported previously in the English language literature was a 13-year-old Korean girl described briefly in a series.⁶ We describe herein the youngest patient with EIB: a 22-month-old boy with EIB secondary to pulmonary tuberculosis. This report emphasizes that recognition, investigation, and treatment of tuberculids is essential in the pediatric age group.

	CASE REPORT

A 22-month-old, previously healthy Asian boy . . . [Full Text of this Article]